A Phase I study of remimazolam for general anesthesia

Trial Profile

A Phase I study of remimazolam for general anesthesia

Phase of Trial: Phase I

Latest Information Update: 23 Mar 2017

At a glance

  • Drugs Remimazolam (Primary)
  • Indications Anaesthesia
  • Focus Adverse reactions
  • Most Recent Events

    • 23 Mar 2017 New trial record
    • 16 Mar 2017 According to a PAION media release, this trial will determine the number of patients required for a EU Phase III study (see profile 259255). Company expects to initiate this trial in 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top